Cancer Treatments
-
{
- All
- News
- Videos
-
Amid Drug Price Cuts, A Look At India's Cancer Burden Against Asian Peers
India records around 1.56 million cancer cases and 9,02,000 deaths in 2025, making it the second-most affected country among selected Asian nations, behind only China.
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
Cancer Misinformation And Unproven Remedies: How Misleading Health Claims Can Affect Treatment Decisions
Cancer differs by type, stage and treatment needs, still social media often promotes unproven remedies as choices to conventional treatment.
-
Supreme Court Flags Massive Gap Between Medicine MRP And Retailer Cost, Asks Government, "Allowing This To Happen?"
The Court was hearing a public interest litigation (PIL) filed by advocate Kishan Chand Jain seeking mandatory generic drug prescriptions, strict initial price controls on non-scheduled medicines, and statutory margin caps on medical devices under the Drug Price Control Order (DPCO).
-
Scientists Develop Albumin-Based System To Produce Anticancer Compounds Inside Tumour Cells
Scientists have developed an experimental system that uses carbon monoxide produced by cancer cells to synthesise potential anticancer drugs. Early laboratory tests showed modest selectivity, but further research is needed before clinical use.
-
Rome Hospital Taps Culture To Help Heal Cancer Patients
With art-filled treatment areas, museum tours and even ancient temple ruins on its grounds, a Rome hospital is hoping culture therapy will boost its...
-
Why Fungal Infections Pose A Severe Risk To Cancer And Transplant Patients
Fungi rarely cause serious disease in healthy people due to immune defenses but pose high risk to immunocompromised patients.
-
Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources
According to official sources in the Department of Pharmaceuticals, the new measure is expected to result in reductions of up to 70% in the MRP of certain cancer medicines. The government estimates that the move could lead to annual savings of around Rs 2,500 crore for patients.
-
4 Years After Her Death, Court Says Centre Can Make Cancer Drug She Needed
The Kerala High Court held that the Centre has the power under the Patents Act to manufacture patented life-saving medicines and sell them at cheaper rates to patients who cannot afford them - a ruling that came after a petition filed by a cancer patient who died before her case could be heard.
-
'Been Worried': Dipika Kakar Opens Up About Red Eyes Amid Cancer Recovery
In a recent video, Dipika Kakar shared health update after experiencing redness in her eyes
-
AI Model That Can Detect Cancer And 150 Conditions? Alibaba Open-Sources Its 'Damo Radar'
Alibaba's DAMO Academy has open-sourced Damo Radar, a medical AI model that detects 146 conditions across 18 abdominal organs via CT scans. Tested on 40,000 scans, it cut missed diagnoses by 10% and diagnostic time by 30%.
-
Access To 12 Childhood Cancer Medicines Will Be Made Easier Globally: WHO
WHO launches a new pathway inviting manufacturers to submit childhood cancer medicines for evaluation under its Prequalification Programme.
-
Leukemia And Lymphoma: New Treatments Offering Hope To Patients
The latest treatment options for leukemia and lymphoma depend on the people who have been diagnosed with it. Dr Pawan Kumar Singh explains the latest treatment options available to patients.
-
Advanced Breast Cancer Drug Fails Key Clinical Trial Days After Regulatory Approval
The SERENA-4 trial included 1,371 patients with previously untreated advanced hormone receptor-positive, HER2-negative breast cancer. Researchers compared camizestrant plus Ibrance with Ibrance and standard hormone-lowering treatment.
-
Amid Drug Price Cuts, A Look At India's Cancer Burden Against Asian Peers
India records around 1.56 million cancer cases and 9,02,000 deaths in 2025, making it the second-most affected country among selected Asian nations, behind only China.
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
Cancer Misinformation And Unproven Remedies: How Misleading Health Claims Can Affect Treatment Decisions
Cancer differs by type, stage and treatment needs, still social media often promotes unproven remedies as choices to conventional treatment.
-
Supreme Court Flags Massive Gap Between Medicine MRP And Retailer Cost, Asks Government, "Allowing This To Happen?"
The Court was hearing a public interest litigation (PIL) filed by advocate Kishan Chand Jain seeking mandatory generic drug prescriptions, strict initial price controls on non-scheduled medicines, and statutory margin caps on medical devices under the Drug Price Control Order (DPCO).
-
Scientists Develop Albumin-Based System To Produce Anticancer Compounds Inside Tumour Cells
Scientists have developed an experimental system that uses carbon monoxide produced by cancer cells to synthesise potential anticancer drugs. Early laboratory tests showed modest selectivity, but further research is needed before clinical use.
-
Rome Hospital Taps Culture To Help Heal Cancer Patients
With art-filled treatment areas, museum tours and even ancient temple ruins on its grounds, a Rome hospital is hoping culture therapy will boost its...
-
Why Fungal Infections Pose A Severe Risk To Cancer And Transplant Patients
Fungi rarely cause serious disease in healthy people due to immune defenses but pose high risk to immunocompromised patients.
-
Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources
According to official sources in the Department of Pharmaceuticals, the new measure is expected to result in reductions of up to 70% in the MRP of certain cancer medicines. The government estimates that the move could lead to annual savings of around Rs 2,500 crore for patients.
-
4 Years After Her Death, Court Says Centre Can Make Cancer Drug She Needed
The Kerala High Court held that the Centre has the power under the Patents Act to manufacture patented life-saving medicines and sell them at cheaper rates to patients who cannot afford them - a ruling that came after a petition filed by a cancer patient who died before her case could be heard.
-
'Been Worried': Dipika Kakar Opens Up About Red Eyes Amid Cancer Recovery
In a recent video, Dipika Kakar shared health update after experiencing redness in her eyes
-
AI Model That Can Detect Cancer And 150 Conditions? Alibaba Open-Sources Its 'Damo Radar'
Alibaba's DAMO Academy has open-sourced Damo Radar, a medical AI model that detects 146 conditions across 18 abdominal organs via CT scans. Tested on 40,000 scans, it cut missed diagnoses by 10% and diagnostic time by 30%.
-
Access To 12 Childhood Cancer Medicines Will Be Made Easier Globally: WHO
WHO launches a new pathway inviting manufacturers to submit childhood cancer medicines for evaluation under its Prequalification Programme.
-
Leukemia And Lymphoma: New Treatments Offering Hope To Patients
The latest treatment options for leukemia and lymphoma depend on the people who have been diagnosed with it. Dr Pawan Kumar Singh explains the latest treatment options available to patients.
-
Advanced Breast Cancer Drug Fails Key Clinical Trial Days After Regulatory Approval
The SERENA-4 trial included 1,371 patients with previously untreated advanced hormone receptor-positive, HER2-negative breast cancer. Researchers compared camizestrant plus Ibrance with Ibrance and standard hormone-lowering treatment.
